Pandemic Perspectives: The Lost Trials Of 2020
Clinical Study Starts Fell 8% Amid COVID-19
New development programs fell sharply in the early part of the year as COVID-19 spread around the world, but activity picked up in the second half. Oncology trials rebounded strongly and infectious disease trials ballooned, but autoimmune and CNS studies took a hit.
